 and Novo Nordisk (NVO) have a "moat" around them. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.){kind=link}
Most companies are likely going to feel the impact of President Trump’s tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the pharmaceutical stocks he covers. He also explains why Eli Lilly (LLY) and Novo Nordisk (NVO) have a “moat” around them.
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
President Trump, Tim Anderson, Novo Nordisk, pharmaceutical stocks, Eli Lilly, BofA Securities, tariffs
#tariffs #impact #pharma #stocks